Please ensure Javascript is enabled for purposes of website accessibility

A Conservative Fund for Thrill Seekers

By Selena Maranjian – Updated Apr 6, 2017 at 1:06PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

From top performer to the bottom quarter. Will he make it back to the top?

If you don't think mutual funds are exciting, think again. Funds can surge and plunge, just like stocks, but a rising fund won't necessarily keep doing so. Still, volatility isn't a reason to rule out a fund. Just look at the Forester Value (FVALX) fund.

When the gruesome year 2008 ended, Forester Value stood alone as the only U.S. stock fund still in the black. Fund manager Tom Forester managed that by avoiding the free-falling financial sector in favor of defensive stocks such as McDonald's and Johnson & Johnson (NYSE: JNJ).

Part of Forester's success was also tied to being heavily in cash for part of the year, thereby avoiding losses with that money. He was reportedly heavy on cash again recently, to the tune of 18% of the fund's assets as of the end of March. If the market surges soon, being in cash could hurt him. Still, a good investor follows his or her convictions, and as of late March, Forester seemed to expect bigger bargains in the future.

The next chapter
After Forester Value's terrific 2008 performance, many people would have expected its success to continue. But the best fund one year can easily be the next year's big loser. Forester wasn't exactly a loser, but it did drop from being in the top 1% of peer-group funds in 2008 to the bottom quarter of the pack in 2009. This yo-yo effect is nothing new: The fund went from first to last between 2003 and 2004.

That said, Forester has beaten the market over the past three, five, and 10 years. When the market has dropped sharply, the fund has often fared especially well, smoothing the overall ride for shareholders.

The future matters most
In Fortune magazine, Forester recently waxed bullish on Hewlett-Packard (NYSE: HPQ), praising its cheapness and expecting HP to benefit as the economy recovers and companies upgrade their technology. He's also recently mentioned Microsoft (Nasdaq: MSFT), which he also expects to benefit from the economic turnaround and from the upcoming release of the new version of Office. These were his fund's top two holdings as of the end of March.

Forester has explained: "I'm basically a low P/E buyer. Low-valuation stocks generally get the best performance over a full market cycle." He's made Bristol-Myers Squibb (NYSE: BMY) and Johnson & Johnson two major recent holdings, both of which have low P/Es around 13. Forester also favors dividend yield, and these companies have good yields and payouts that have risen over time. In addition, he's carrying a fair amount of cash, suggesting that he sees better bargains on the horizon.

If you want a conservative, value-focused manager at the helm, then Forester Value is a fund worth considering -- provided you've got the stomach for its ups and downs.

Microsoft is a Motley Fool Inside Value pick. Johnson & Johnson is a Motley Fool Income Investor selection. Motley Fool Options has recommended buying calls on Johnson & Johnson and a diagonal call position on Microsoft. Try any of our Foolish newsletter services free for 30 days.

Longtime Fool contributor Selena Maranjian owns shares of Johnson & Johnson, McDonald's, and Microsoft. The Motley Fool is Fools writing for Fools.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

HP Inc. Stock Quote
HP Inc.
HPQ
$24.96 (-1.54%) $0.39
Microsoft Corporation Stock Quote
Microsoft Corporation
MSFT
$237.45 (-0.20%) $0.47
Johnson & Johnson Stock Quote
Johnson & Johnson
JNJ
$165.70 (-0.61%) $-1.02
Bristol Myers Squibb Company Stock Quote
Bristol Myers Squibb Company
BMY
$70.15 (-0.79%) $0.56

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.